Childhood Cancer Survival Hits 85% Thanks to Research

When a child rings the hospital bell after cancer treatment, nearly half of Americans think the medical journey is over. The truth is more complicated, but there's genuine hope in the progress being made.

Childhood cancer survival rates have climbed to 85% for five-year survival, up from 75% just three decades ago. That's thousands more children getting the chance to grow up, thanks to dedicated research investments.

Hyundai Hope on Wheels has committed over $300 million to pediatric cancer research over the past 28 years. Those funds have supported more than 1,600 grants across 210 medical institutions nationwide, directly impacting thousands of young patients and their families.

Isabella Franco-Capps knows the reality behind those numbers. Diagnosed with B-cell acute lymphoblastic leukemia at age 5, she spent two years navigating scans, chemotherapy, and hospital stays before becoming a cancer survivor at age 7.

Now 11, Isabella serves as a Hyundai Hope on Wheels National Youth Ambassador. She's joined by Jackson Trihn, 12, who uses his voice to spread awareness about what pediatric cancer families really face.

Why This Inspires

The rising survival rate represents real scientific progress, but advocates are pushing for something equally important: understanding that healing continues long after treatment ends. Executive Director John Guastaferro emphasizes that sustained investment in survivorship care remains a priority, addressing the physical and emotional needs that persist for years.

Jackson Trihn puts it simply: people don't understand how hard pediatric cancer can be. By sharing their stories, these young ambassadors are changing that, one conversation at a time.

The progress from 75% to 85% survival means roughly 1,750 more children survive cancer each year in the United States alone. Each percentage point represents real kids who get to celebrate birthdays, start middle school, and dream about their futures.

Research funding continues to drive innovation in treatment while new programs support survivors through the challenges that follow remission. The focus has expanded from simply surviving to thriving after cancer.

Every child who rings that hospital bell deserves comprehensive care that extends far beyond their last treatment.